logo inner

Director, Pharmacovigilance

4D Molecular TherapeuticsEmeryville, California, United StatesOnsite
This job is no longer open

Attention recruitment agencies:


All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products.

We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.  Company Differentiators: •    Fully integrated clinical-phase company with internal manufacturing•    Demonstrated ability to move rapidly from idea to IND•    Five candidate products in the clinic and two declared pre-clinical programs•    Robust technology and IP foundation, including our TVE and manufacturing platforms•    Initial product safety and efficacy data substantiates the value of our platforms•    Opportunities to expand to other indications and modalities within genetic medicine

GENERAL SUMMARY: 


The Director of Pharmacovigilance is responsible for implementing and coordinating pharmacovigilance activities for 4DMT products.  This position will be a knowledge leader for 4DMT products and actively participate in safety related aspects of the product life cycle from development to post-marketing to ensure rigorous analysis, critical decision making, and communication of safety information to internal 4DMT groups and regulatory authorities.  It is expected that this person will develop a proactive, forward-looking program of communicating safety information and directions for safety product use to stakeholders both internal and external.  Knowledge of safety operations and systems is important to this position.The person will be a key interface and participant with internal 4DMT groups such as Clinical Science, Clinical Operations, Regulatory, and Compliance/Quality.

Documentation of the origin, ongoing history, and closure of safety issues will be critical.The person will ensure corporate compliance with domestic and international adverse event and safety issue reporting requirements, interpreting the medical significance of incoming safety information, and performing regular risk management assessments of assigned products. 

RESPONSIBILITIES:  


  • Act as safety leader with responsibility for signal detection and assessment activities for 4DMT products. Example:
  • Signal summary reports;
  • Tracking and using safety database tools for aggregating safety data; 
  • Leading cross functional teams to assess safety signals; 
  • Creation of action plans to mitigate/manage product risks; 
  • Responding to safety associated Health Authority requests; 
  • Development and maintenance of product Risk Management Plans (RMP); 
  • Monitor the safety profile of delegated products and recommend appropriate action including labeling amendments and risk management programs when warranted assess product specific adverse event information to determine required action based on internal policies; 
  • Providing medical assessment as relevant.
  • Participation in maintaining and upgrading pharmacovigilance processes. These may include MedDRA maintenance, PV systems policies, and implementation of new regional and cross-regional PV regulations. 
  • Ensures corporate compliance with domestic and international adverse event and safety issue reporting requirements for delegated products.
  • Prepare safety-related sections and associated documentation for clinical and regulatory documents (i.e. clinical study protocols, clinical study final reports, IND annual reports, integrated summaries of safety, annual safety reports, Investigator Brochures, Development Safety Update Reports (DSUR), and Annual safety update reports (ASUR), and other aggregate reports).
  • Review ICFs, clinical study non-serious adverse event line listings and other study related documents containing safety information.
  • May assist with approving, reviewing, and contributing to publications (abstracts, posters, papers) for scientific meetings/journals.
  • Assists with contributing to safety components of strategic documents and to development of Target Product Profile (TPP).
  • Act as the safety liaison/resource on study project teams for safety related issues relating to clinical development.
  • Supervise PV activities and personnel related to licensing partners and CROs.
  • Provides support as required for licensing activities, regulatory authority inspections audits and for project product recall activities.
  • Collaborates with other departments (e.g., training) to provide expertise and guidance to personnel for interdepartmental and cross-functional team activities, including process improvement standards and metrics.
  • Interacts with service providers as required to address safety queries, share best practices, and discuss new safety regulations.

Provides regional support for activities associated with safety compliance, operations, and medical review as needed. 

QUALIFICATIONS: 


  • MD, PharmD., RN, BSN, Nurse Practitioner, Pharmacist or related degree with at least 5+ years pharmaceutical industry, pharmaceutical industry safety surveillance, or applicable clinical/medical experience required.
  • Demonstrated knowledge of domestic and international ADE reporting regulations per guidelines and follow timelines as necessary for regulatory reporting purposes.
  • Demonstrated knowledge and proficiency with drug safety databases (i.e. ARISg or ARGUS)
  • Proficiency with standard office skills and standard desktop computing programs
  • Excellent oral and written communication skills with excellent interpersonal skills and willingness to work in a team environment, cross functionally, and work with multiregional organizations.
  • Highly organized and demonstrates understanding of workflow prioritization.
  • Ability to multitask and triage as needed with the ability to work independently, under pressure, demonstrating initiative and flexibility.
  • Excellent understanding of clinical trial methodology, GCP and medical terminology
  • Attention to detail and quality focused with strong technical and problem-solving skills

  • Strong organizational and project management skills

  • Strong communication skills and the ability to operate effectively in an international environment

  • Excellent understanding of physiology, pharmacology, clinical study objectives, and the drug development process
  • Strong computer skills including, but not limited to, creation of spreadsheets, templates, presentations and working with safety database applications.

Compensation Range: $210,000/year - $270,000/yearPlease note, the base salary compensation range and actual salary offered to the final candidate depends on various factors: candidate’s geographical location, relevant work experience, skills, and years of experience.4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

This job is no longer open

Life at 4D Molecular Therapeutics

The mission of 4D Molecular Therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions. Our products are unlocking the full potential of gene therapy to treat, and potentially cure, genetic diseases. A large number of patients and diseases, who previously were not treatable by gene therapy, will be addressable by 4D products. 4D has one of the deepest and most diverse product pipelines in the gene therapy field. Adeno-associated virus (AAV) vectors have emerged as a favored delivery vehicle for gene therapy in the human body. They can deliver the genes for therapeutic proteins to accessible tissues in the body and are generally considered safe. Several AAV gene therapy products are in late-stage clinical development, and one product is approved in the EU (Glybera, Uniqure). However, these first-generation AAV vectors have limited utility for the majority of diseases. Many of these common AAV were discovered as laboratory contaminants and monkey infections, for example; they have not been customized as targeted medicines. In contrast, 4D customized AAV vectors, and the products made from them, are designed to unlock the full potential of gene therapy. Through 4D's Therapeutic Vector Evolution, we are able to create customized vectors solutions to overcome the hurdles identified with first-generation AAV vectors. 4D is creating the ultimate gene therapy products to cure genetic diseases using new customized delivery vehicles (vectors) to shuttle genes into the cells in any organ in the body. This 4D library of vectors will soon include several for the liver, several for the brain, several for the heart, the eye, muscle, and so on. Doctors will be able to hand pick a vector for any patient based on the organ that is diseased.
Thrive Here & What We Value1. Collaborative and innovative work environment2. Emphasis on scientific excellence and innovation3. Focus on patient outcomes and improving lives through genetic medicine4. Opportunities for career growth and professional development5. Commitment to diversity, equity, and inclusion6. Robust technology and IP foundation, including TVE and manufacturing platforms7. Initial product safety and efficacy data substantiates platform value8. Rapid progression from idea to IND9. Expanding opportunities in genetic medicine indications and modalities10. Internal manufacturing capabilities
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024